Compare ARK Genomic Revolution ETF (ARKG) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? ARK Genomic Revolution ETF trades at $41, while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.14. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | XDTE | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $43.57 | $44.76 |
52-Week Low | $23.09 | $36.00 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XDTE trades at $39.20, up 0.44% today, but technical indicators signal a bearish trend with resistance at $39. The ETF generates high income through weekly dividends, with recent payouts ranging from $0.09 to $0.26, but faces NAV erosion risks. News highlights its role in providing frequent distributions via covered call strategies on S&P 500 options.
Outlook is cautious due to technical weakness and fundamental risks from NAV declines despite high yields. Investors may value the tax-efficient weekly income, but must weigh sustainability concerns if market sentiment shifts negatively. The bearish technical setup suggests limited near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
